Breaking News Instant updates and real-time market news.

QD

Qudian

$14.22

0.07 (0.49%)

, ROKU

Roku

$40.44

-1.08 (-2.60%)

08:45
02/27/18
02/27
08:45
02/27/18
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: (QD) 50.36% +0.24, (ROKU) 49.75% +0.12, Verizon (VZ) 0.33% +0.08, United Technologies (UTX) 0.29% +0.04, Altaba Inc (AABA) 0.29% +0.04, iShares Silver Trust (SLV) 0.83% +0.01, MiMedx (MDXG) 20.01% +0.01, Energous (WATT) 43.94% +0.01, and FXI (FXI) 1.48% +0.01.

QD

Qudian

$14.22

0.07 (0.49%)

ROKU

Roku

$40.44

-1.08 (-2.60%)

VZ

Verizon

$49.09

0.8 (1.66%)

UTX

United Technologies

$135.47

2.32 (1.74%)

AABA

Altaba

$78.08

0.32 (0.41%)

SLV

iShares Silver Trust

$15.68

0.09 (0.58%)

MDXG

MiMedx

$7.35

-0.48 (-6.13%)

WATT

Energous

$22.46

0.02 (0.09%)

FXI

iShares China Large-Cap ETF

$50.34

0.64 (1.29%)

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 05

    Mar

  • 07

    Mar

  • 11

    Mar

  • 12

    Mar

  • 14

    Mar

  • 16

    Mar

  • 21

    Mar

QD Qudian
$14.22

0.07 (0.49%)

01/26/18
STFL
01/26/18
DOWNGRADE
STFL
Hold
Qudian downgraded to Hold from Buy at Stifel
11/27/17
STFL
11/27/17
NO CHANGE
Target $19
STFL
Buy
Qudian price target lowered to $19 from $35 at Stifel
Stifel analyst John Davis estimates Alipay's recently announced rate cap could result in as much as a 25% earnings hit to Qudian, but he also believes in that context that the more than 50% correction in the stock is overdone. Headlines about a data leak/breach are unconfirmed, added Davis, who cut his price target on Qudian shares to $19 from $35 but maintains a Buy rating on the stock.
12/05/17
NEED
12/05/17
NO CHANGE
NEED
Qudian price target lowered to $20 from $30 at Needham
Needham analyst Mayank Tandon lowered his price target on Qudian shares to $20 from $30, noting recent news that could create near-term headwinds for the company, including Ant Financial announcing a 24% APR cap for all third-party credit services on its Alipay interface, and PBOC and CRBC releasing a new regulation notice that outlined principles and additional guidelines related to the cash loan business in China. Despite these potential headwinds, Tandon believes Qudian's fundamentals remain in tact, and maintained a Buy rating on Qudian shares.
01/26/18
01/26/18
DOWNGRADE
Target $15

Hold
Qudian downgraded to Hold amid China cash loan industry turmoil at Stifel
As previously reported, Stifel analyst John Davis downgraded Qudian to Hold from Buy, stating that the near-term outlook is muddied by expected higher credit losses and a significant shift in business model due to the current turmoil in the Chinese cash loan industry. While he thinks Qudian will ultimately benefit from recent regulations in the form of reduced competition, he prefers to move to the sidelines "while the dust settles," he tells investors. Davis lowered his price target on Qudian shares to $15 from $19.
ROKU Roku
$40.44

-1.08 (-2.60%)

02/22/18
RBCM
02/22/18
NO CHANGE
Target $45
RBCM
Sector Perform
Roku price target raised to $45 from $28 at RBC Capital
RBC Capital analyst Mark Mahaney raised his price target on Roku to $45 after the company's Q4 results, saying the adjusted EBITDA was well above consensus while the EBITDA margin of 8% was a record high. Mahaney adds that Q4 fundamentals were strong, with very slight deceleration in platform revenue growth and overall margin expansion. Mahaney keeps his Sector Perform rating on Roku.
02/22/18
NEED
02/22/18
NO CHANGE
Target $50
NEED
Strong Buy
Needham says buy Roku amid 18% selloff given discount to Netflix
Needham analyst Laura Martin recommends using the post-earnings selloff in shares of Roku (ROKU) as a buying opportunity. The stock in premarket trading is down 18%, or $9.40, to $41.90. Martin keeps a Buy rating on the shares with a $50 price target. The stock will open lower based on a non-cash accounting change to Accounting Standards Codification 606 that lowers Roku's projected gross profit, adjusted EBITDA and earnings, Martin tells investors in a research note. The analyst, however, expects ASC 606 to elevate Roku's reported revenue and costs, which she feels is helpful, noting the stock likely trades on a multiple of forward revenue. At 7.0 times, Roku trades at a "sharp discount" to its closest comp, Netflix (NFLX), which trades at 10.7 times, Martin contends. She thinks investors should own Roku given the "steep discount" to Netflix despite "comparable growth credentials, a better margin profile, lower content risks, and little competitive threat from new OTT channel launches."
02/22/18
SBSH
02/22/18
NO CHANGE
Target $33
SBSH
Sell
Roku price target raised to $33 from $28 at Citi
Citi analyst Mark May views Roku's Q4 report as mixed, as upside in Platform/Advertising revenue was offset by lower than expected Player revenue. He notes, however, that upside in Platform/Advertising revenue did produce upside to earnings guidance and forecasts. The analyst raised his price target for Roku shares to $33 from $28 and keeps a Sell rating on the name. May believes bulls were likely expecting a higher profit and EBITDA outlook given the valuation.
02/20/18
SBSH
02/20/18
NO CHANGE
Target $28
SBSH
Sell
Roku added to Positive Catalyst Watch list at Citi
Citi analyst Mark May added Roku to his firm's Positive Catalyst Watch list saying the company's Q4 report could produce upside to consensus estimates and the stock. The analyst, however, continues to believe that the current valuation assumes an overly optimistic long-term view of the potential size of the company's advertising business. He keeps a Sell rating on Roku with a $28 price target.
VZ Verizon
$49.09

0.8 (1.66%)

02/14/18
02/14/18
UPGRADE
Target $9

Outperform
Calix upgraded to Outperform with $9 price target at Northland
As previously reported, Northland analyst Tim Savageaux upgraded Calix (CALX) to Outperform from Market Perform, stating that while its Q4 results missed expectations the company looks to have meaningfully addressed its operating expense and gross margin issues. While he expects slower growth as a ramp at Verizon (VZ) offsets weakness at CenturyLink (CTL), he estimates the company will turn from a loss to "solid profits" in FY18, Savageaux tells investors. He set a $9 price target on Calix shares.
02/13/18
02/13/18
NO CHANGE

AT&T the first carrier to offer BOGO deal for iPhone X, says Wells Fargo
Wells Fargo analyst Jennifer Fritzsche noted that AT&T (T) is the first cell phone carrier to offer a Buy One Get One Free, or BOGO, promotion on the Apple (AAPL) iPhone X, and highlighted that the deal has no requirement regarding new customers or trading in old devices. She said it is unclear if any other carrier will match the deal, although she noted that Verizon (VZ) and T-Mobile (TMUS) had attractive deals, although no true BOGO deal. Fritzsche also mentioned that AT&T has the "largest embedded base of iPhone users to protect," as it had iPhone exclusivity until 2011. Fritzsche has an Outperform rating and $48 price target on AT&T shares.
01/31/18
DBAB
01/31/18
NO CHANGE
Target $15
DBAB
Sell
GE likely to be dropped from Dow 30 index, says Deutsche Bank
General Electric (GE) is likely to be dropped from the Dow Jones Industrial Average after being in the index of 30 companies for over 110 years as an original member since 1896, Deutsche Bank analyst John Inch tells investors in a research note. The chances that GE could be removed from the Dow are increasing as the company continues to face "substantial challenges," the analyst writes. These include "earnings and cash pressure, tough global power generation markets, aggressive downsizing, shrinking its portfolio, management shake-up and SEC investigations," Inch argues. He sees "headline risk" as the most significant risk factor if GE were to be dropped from the Dow, "potentially amplified by GE's high mix of retail investors." Inch notes that the last major Dow shakeup occurred in September 2003, when American Airlines (AAL), Bank of America (BAC) and Hewlett Packard (HPQ) were removed and Goldman Sachs (GS), Nike (NKE) and Verizon (VZ) were added. Inch has a Sell rating on General Electric with a $15 price target. The shares closed yesterday down 33c to $15.95.
01/24/18
RHCO
01/24/18
NO CHANGE
Target $58
RHCO
Hold
Verizon price target raised to $58 from $52 at SunTrust
SunTrust analyst Greg Miller raised his price target on Verizon to $58 after "in-line to slightly better than expected" Q4 earnings, with solid wireless performance offset by weaker wireline. The analyst notes that the company's management remains confident in sustaining its network quality advantage in the 5G world while also leveraging its media partnerships to drive engagement. Miller keeps his Hold rating on Verizon.
UTX United Technologies
$135.47

2.32 (1.74%)

02/09/18
ARGS
02/09/18
UPGRADE
ARGS
Buy
United Technologies upgraded to Buy from Hold at Argus
02/09/18
ARGS
02/09/18
UPGRADE
Target $150
ARGS
Buy
United Technologies upgraded to Buy at Argus on infrastructure spending prospect
As reported earlier, Argus analyst John Eade upgraded United Technologies to Buy from Hold with a price target of $150. Eade says the company remains a leader in a number of global industries and should continue to benefit from population growth and middle class expansion in developing markets. The analyst adds that the stock has outperformed the market over the past quarter and should see more upside ahead given the optimism over reduced corporate tax rates and prospects for increased infrastructure spending. Eade says his valuation gives him a price target of $140 on comparative multiple analysis and $160 based on his dividend discount model.
02/09/18
02/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Sector Perform from Underperform at RBC Capital with analyst Mark Mahaney saying the fourth quarter revenue and EBITDA were materially better than expected, and while MAU's were below consensus, DAU's grew for the first time at a double-digit rate. 2. iRobot (IRBT) upgraded to Outperform from Market Perform at Raymond James with analyst Mark Strouse saying he sees a more balanced risk/reward following the recent pullback in the shares. 3. Regeneron (REGN) upgraded to Outperform from Neutral at Baird with analyst Brian Skorney noting its selloff since last year and believes its valuation has reached a point where the selloff is overdone. 4. Teva (TEVA) upgraded to Sector Perform from Underperform at RBC Capital with analyst Randall Stanicky saying the 11% sell-off in the stock price following the company's guidance update has removed the debate around 2018 EBITDA target and sees limited downside from the current levels. 5. United Technologies (UTX) upgraded to Buy from Hold at Argus with analyst John Eade saying the company remains a leader in a number of global industries and should continue to benefit from population growth and middle class expansion in developing markets. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/15/18
LEHM
02/15/18
INITIATION
Target $157
LEHM
Overweight
United Technologies initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started United Technologies with an Overweight rating and $157 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
AABA Altaba
$78.08

0.32 (0.41%)

02/22/18
UBSW
02/22/18
NO CHANGE
Target $98
UBSW
Buy
Altaba price target raised to $98 from $92 at UBS
UBS analyst Eric Sheridan raised his price target on Altaba to $98 from $92 ahead of the company's strategic and financial update call next week. He believes the call will include an update on the company's tax status, its view of asset value, and its forward capital structure and shareholder return policy. Sheridan reiterated his Buy rating on Altaba shares.
02/23/18
JPMS
02/23/18
NO CHANGE
Target $90
JPMS
Overweight
Altaba price target raised to $90 from $65 at JPMorgan
JPMorgan analyst Doug Anmuth raised his price target for Altaba (AABA) to $90 ahead of the company's strategic and financial update conference call on February 27. Corporate tax reform in the U.S. lowers Altaba's potential tax liability from 36.5% to an estimated 22.5% in any taxable monetization of its Alibaba (BABA) or Yahoo Japan (YAHOY) stakes, Anmuth tells investors in a research note. He notes that Altaba now trades at a 26% discount to pre-tax net asset value. The analyst keeps an Overweight rating on the name.
02/23/18
MKMP
02/23/18
NO CHANGE
Target $112
MKMP
Buy
Altaba price target raised to $112 from $76 at MKM Partners
MKM Partners analyst Rob Sanderson raised his price target on Altaba to $112 and kept his Buy rating ahead of next week's investor call. Sanderson believes that having "more conclusive" details of tax reform will allow the company to take more aggressive action to unlock shareholder value, given "high management appetite" for more share buybacks.
11/07/17
OPCO
11/07/17
NO CHANGE
Target $99
OPCO
Outperform
Altaba price target raised to $99 from $75 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Altaba (AABA) to $99 from $75 following a more bullish outlook for the shares and due to Alibaba's (BABA) price target increase to $220 from $200. The analyst reiterates an Outperform rating on Altaba's shares.
SLV iShares Silver Trust
$15.68

0.09 (0.58%)

MDXG MiMedx
$7.35

-0.48 (-6.13%)

02/23/18
CHLM
02/23/18
NO CHANGE
Target $19
CHLM
Buy
MiMedx fundamentals, execution should ultimately 'win out,' says Craig-Hallum
Craig-Hallum analyst Matt Hewitt noted that MiMedx management hosted an update call to address investor concerns about the recently announced investigation into sales practices and accounting, during which they revealed that King & Spalding has been hired as an independent legal advisor and KPMG will provide forensic accounting services. Uncertainty surrounding the investigation and recent short seller attacks have pushed shares over 50% off of their highs, but Hewitt ultimately thinks the company's fundamentals and strong execution will "win out," making the stock "intriguing" at current levels, he tells investors. He keeps a Buy rating and $19 price target on MiMedx shares.
02/23/18
LSCM
02/23/18
DOWNGRADE
LSCM
Hold
MiMedx downgraded to Hold from Buy at Lake Street
02/21/18
LSCM
02/21/18
NO CHANGE
Target $12
LSCM
Buy
Lake Street says MiMedx remains 'real company,' cuts price target to $12
Lake Street analyst Bruce Jackson lowered his price target for MiMedx Group to $12 from $18 after the company delayed the release of its Q4 results after the board's audit committee requested independent legal and accounting investigations. While the near-term picture "might be uncertain," MiMedx continues to be a "real company" with revenue of $324M that grew more than 30% in 2017, Jackson tells investors in a research note. He sees the company's "strong" gross margins and "promising" new product pipeline limiting downside risk from current share levels. Nonetheless, the internal investigation represents a "significant overhang" on the stock until it is resolved, which implies multiple compression, the analyst adds. He keeps a Buy rating on MiMedx.
02/23/18
02/23/18
DOWNGRADE
Target $9

Hold
MiMedx downgraded to Hold with $9 price target at Lake Street
As previously reported, Lake Street analyst Bruce Jackson downgraded MiMedx to Hold from Buy, stating that a resolution of the investigation into current and prior period sales and distribution practices is unlikely to be swift and the shares are unlikely to outperform until the investigation is resolved. If the investigation resolves favorably, the upside potential "would be significant and he would be an aggressive buyer of the stock, but for now Jackson cut his price target on MiMedx shares to $9 from $12.
WATT Energous
$22.46

0.02 (0.09%)

03/09/17
LTCO
03/09/17
NO CHANGE
Target $18
LTCO
Buy
Ladenburg ups Energous target to $18 post Q4 results
Ladenburg Thalmann analyst Jon Hickman raised his price target for Energous to $18 from $16.75 following the company's Q4 results. On the earnings call, management highlighted the company's relationship with Dialog Semiconductor, its progress in meeting the requirements for FCC certification of the mid-range transmitter and the successful completion the new integrated 4100 chip-set, Hickman tells investors in a research note. The analyst is now more confident that Energous is on track to achieve "meaningful product revenues" in 2017. He keeps a Buy rating on the shares.
05/02/17
JPMS
05/02/17
NO CHANGE
Target $260
JPMS
Overweight
JPMorgan now confident Broadcom's wireless charging is in upcoming iPhone
JPMorgan analyst Harlan Sur says his recent work indicates Apple (AAPL) will integrate Broadcom's (BRCM) wireless charging chip into its upcoming iPhone launch in the second half of 2017. In his initial report on the subject in February, Sur was unclear whether or not Apple would be integrating wireless charging into this year's iPhone launch. The February report sent shares of Energous (WATT) lower. Since that report, Sur has learned that Broadcom is getting set to commence manufacturing production of the wireless charging chip with its foundry partners in May. Sur believes Apple will also use Broadcom's next generation WiFi/Bluetooth combo chip and maybe two ASIC chips instead of one. There is at least a $2-$3 step-up in dollar content per phone from the new wireless charging chip, new touch controller chips and upgraded wireless connectivity content in the upcoming iPhones, which is "significantly" higher than what the market is anticipating, Sur tells investors in a research note. He reiterates an Overweight rating on Broadcom with a $260 price target. The stock closed yesterday up 51c to $221.32.
12/28/17
ROTH
12/28/17
NO CHANGE
Target $45.8
ROTH
Buy
Energous price target raised to $45.80 from $22.80 at Roth Capital
Roth Capital analyst William Gibson raised his price target for Energous to $45.80 from $22.80 based on the NPV of all losses and net income over ten years from 2015 through 2024. The analyst notes that the Federal Communications Commission certified Energous' WattUp Mid Field transmitter, making it the first-ever FCC approved charger capable of transferring power wirelessly up to three feet over RF frequencies. This puts the guidelines in place for new WattUp technologies in coming weeks and months with more power, functionality, and scale, he adds. Gibson reiterates a Buy rating on the shares.
01/05/18
OPCO
01/05/18
NO CHANGE
OPCO
Energous reached major milestone last week, says Oppenheimer
Oppenheimer analyst Andrew Uerkwitz says that after after several years and multiple iterations, Energous accomplished a "major milestone" last week with the FCC approving its distance charging solution. While the importance shouldn't be overlooked, going forward it's all about execution, Uerkwitz tells investors in a research note. The analyst, not wanting to "get ahead of our skis," reiterates a Perform rating on Energous. The analyst believes his model, that derives a potential fair value of $24 for the stock, is unreliable "due to minor changes yielding major moves."
FXI iShares China Large-Cap ETF
$50.34

0.64 (1.29%)

TODAY'S FREE FLY STORIES

BV

BrightView

$21.95

0.14 (0.64%)

05:29
07/23/18
07/23
05:29
07/23/18
05:29
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMO

Sangamo

$15.10

0.025 (0.17%)

05:28
07/23/18
07/23
05:28
07/23/18
05:28
Hot Stocks
Sangamo to acquire TxCell for EUR 2.58 per share in cash »

Sangamo Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BV

BrightView

$21.95

0.14 (0.64%)

05:27
07/23/18
07/23
05:27
07/23/18
05:27
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCM

Hutchison China MediTech

$33.92

0.89 (2.69%)

05:25
07/23/18
07/23
05:25
07/23/18
05:25
Hot Stocks
Chi-Med initiates Phase Ib/II proof-of-concept study of sulfatib »

Hutchison China MediTech,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

05:23
07/23/18
07/23
05:23
07/23/18
05:23
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

05:22
07/23/18
07/23
05:22
07/23/18
05:22
Hot Stocks
Roche receives CE Mark for Accu-Chek Solo micropump system »

Roche announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

PZZA

Papa John's

$51.61

0.62 (1.22%)

05:22
07/23/18
07/23
05:22
07/23/18
05:22
Hot Stocks
Papa John's adopts limited duration stockholder rights plan »

Papa John's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

05:21
07/23/18
07/23
05:21
07/23/18
05:21
General news
Trump tells Iranian President to 'never, ever threaten' U.S. again »

President Trump tweeted…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STIM

Neuronetics

$26.27

-0.44 (-1.65%)

05:19
07/23/18
07/23
05:19
07/23/18
05:19
Initiation
Neuronetics initiated  »

Neuronetics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$51.61

0.62 (1.22%)

05:17
07/23/18
07/23
05:17
07/23/18
05:17
Downgrade
Papa John's rating change  »

Papa John's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$166.47

-0.47 (-0.28%)

05:16
07/23/18
07/23
05:16
07/23/18
05:16
Hot Stocks
Accenture forms strategic alliance with Ripjar, terms not disclosed »

Accenture has formed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 06

    Aug

BV

BrightView

$21.95

0.14 (0.64%)

05:12
07/23/18
07/23
05:12
07/23/18
05:12
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCDA

Tricida

$29.50

-0.42 (-1.40%)

05:10
07/23/18
07/23
05:10
07/23/18
05:10
Initiation
Tricida initiated  »

Tricida initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BV

BrightView

$21.95

0.14 (0.64%)

05:08
07/23/18
07/23
05:08
07/23/18
05:08
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSM

Insmed

$24.98

-0.12 (-0.48%)

05:07
07/23/18
07/23
05:07
07/23/18
05:07
Initiation
Insmed initiated  »

Insmed initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 28

    Sep

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

05:04
07/23/18
07/23
05:04
07/23/18
05:04
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

05:01
07/23/18
07/23
05:01
07/23/18
05:01
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$80.64

-0.56 (-0.69%)

04:58
07/23/18
07/23
04:58
07/23/18
04:58
Upgrade
Duke Energy rating change  »

Duke Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

STI

SunTrust

$70.86

1.855 (2.69%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Upgrade
SunTrust rating change  »

SunTrust upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
RBC Capital commodity strategist to hold a dinner meeting »

Commodity Strategist…

MGEN

Miragen Therapeutics

$6.87

-0.08 (-1.15%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
Miragen Therapeutics management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

04:55
07/23/18
07/23
04:55
07/23/18
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

SAR

Saratoga Investment

$24.59

0.08 (0.33%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
Saratoga Investment management to meet with Compass Point »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

04:55
07/23/18
07/23
04:55
07/23/18
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

NTEC

Intec Pharma

$4.75

(0.00%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
Intec Pharma management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.